Barclays PLC Ocular Therapeutix, Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Barclays PLC holds 511,522 shares of OCUL stock, worth $5.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

511,522

Previous 373,081 37.11%

Holding current value

$5.07 Million

Previous $2.55 Million 74.34%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$6.45 - $9.23 $892,944 - $1.28 Million	138,441 Added 37.11%	511,522 $4.45 Million
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $50,349 - $104,175	11,988 Added 3.32%	373,081 $2.55 Million
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $966,299 - $2.74 Million	250,987 Added 227.95%	361,093 $3.29 Million
Q4 2023 Feb 15, 2024	BUY	$2.08 - $4.52 $175,017 - $380,326	84,143 Added 324.09%	110,106 $491,000
Q3 2023 Nov 07, 2023	BUY	$3.14 - $5.04 $15,197 - $24,393	4,840 Added 22.91%	25,963 $81,000
Q2 2023 Aug 03, 2023	SELL	$4.6 - $7.64 $1.19 Million - $1.98 Million	-258,564 Reduced 92.45%	21,123 $109,000
Q1 2023 May 04, 2023	SELL	$2.79 - $6.27 $109,220 - $245,451	-39,147 Reduced 12.28%	279,687 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $823,629 - $1.39 Million	315,567 Added 9659.23%	318,834 $896,000
Q3 2022 Nov 03, 2022	SELL	$4.09 - $6.5 $53,587 - $85,163	-13,102 Reduced 80.04%	3,267 $14,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $48,497 - $84,104	-16,112 Reduced 49.6%	16,369 $66,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $448,373 - $682,307	-92,831 Reduced 74.08%	32,481 $161,000
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $305,382 - $598,370	49,575 Added 65.46%	125,312 $873,000
Q3 2021 Nov 09, 2021	BUY	$9.7 - $14.34 $575,879 - $851,351	59,369 Added 362.71%	75,737 $757,000
Q2 2021 Aug 13, 2021	SELL	$13.43 - $19.16 $661,602 - $943,879	-49,263 Reduced 75.06%	16,368 $231,000
Q1 2021 May 13, 2021	BUY	$15.82 - $22.11 $683,471 - $955,218	43,203 Added 192.63%	65,631 $1.08 Million
Q4 2020 Feb 11, 2021	SELL	$7.91 - $22.95 $63,430 - $184,036	-8,019 Reduced 26.34%	22,428 $464,000
Q3 2020 Nov 12, 2020	BUY	$7.36 - $9.87 $6,447 - $8,646	876 Added 2.96%	30,447 $231,000
Q2 2020 Aug 12, 2020	BUY	$4.67 - $8.95 $72,581 - $139,100	15,542 Added 110.78%	29,571 $246,000
Q1 2020 May 13, 2020	SELL	$3.95 - $7.4 $112,322 - $210,426	-28,436 Reduced 66.96%	14,029 $70,000
Q4 2019 Feb 10, 2020	SELL	$2.57 - $4.73 $35,291 - $64,952	-13,732 Reduced 24.44%	42,465 $168,000
Q3 2019 Nov 14, 2019	SELL	$3.04 - $5.32 $29,080 - $50,891	-9,566 Reduced 14.55%	56,197 $171,000
Q2 2019 Aug 14, 2019	BUY	$2.46 - $4.52 $105,497 - $193,840	42,885 Added 187.45%	65,763 $290,000
Q1 2019 May 15, 2019	BUY	$3.51 - $4.77 $2,277 - $3,095	649 Added 2.92%	22,878 $91,000
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $97,202 - $178,581	-25,117 Reduced 53.05%	22,229 $88,000
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $126,036 - $162,545	23,254 Added 96.52%	47,346 $325,000
Q2 2018 Aug 14, 2018	SELL	$5.99 - $8.17 $24,978 - $34,068	-4,170 Reduced 14.75%	24,092 $162,000
Q1 2018 May 15, 2018	BUY	$4.66 - $7.08 $112,529 - $170,967	24,148 Added 586.97%	28,262 $184,000
Q4 2017 Feb 14, 2018	SELL	$3.73 - $6.37 $16,434 - $28,066	-4,406 Reduced 51.71%	4,114 $18,000
Q3 2017 Nov 14, 2017	BUY	$5.28 - $6.88 $44,985 - $58,617	8,520	8,520 $52,000

Others Institutions Holding OCUL

# of Institutions

172

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $764M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account